Le Lézard
Classified in: Health, Science and technology, Business
Subject: CON

Entopsis Exploring Strategic Alternatives for its OpsisDxtm Platform


MEDLEY, Fla., Oct. 7, 2021 /PRNewswire/ -- Entopsis, Inc., the developer of an unbiased approach to diagnostics using bio-molecular signatures with a focus on oncology, today announced that it has engaged Berkery Noyes & Co. as its financial advisor to assist the company in pursuing strategic alternatives for their OpsisDxTM platform.

OpsisDxTM is a urine-based technology platform that shifts the focus away from conventional RNA and DNA approaches, offering a highly sensitive and specific diagnostic test for the detection of early-stage cancers. Its IP-protected platform detects urine chemical signatures via a proprietary array, achieving clinically significant results through its proprietary machine learning algorithms. Validation studies on OpsisDxTM have initially focused on detecting early-stage cancers, and the platform has now expanded to detecting multiple other diseases in a highly scalable fashion.

"Now is the time to launch OpsisDxTM. There's greater acceptance of multi-disease testing platforms from a scientific, regulatory and business perspective; the industry as a whole has crossed the tipping point," said Obdulio Piloto, CEO of Entopsis Inc. "We are seeking an established partner who shares our vision of empowering people with actionable, low costs and accurate healthcare information with an eye towards the long-term interests of Entopsis." 

Please direct all inquiries to Lou Grecco (lou.grecco@berkerynoyes.com) and Steven Quinn (steven.quinn@berkerynoyes.com) at Berkery Noyes & Co.

 

SOURCE Berkery, Noyes & Co.


These press releases may also interest you

at 08:49
The rapid spread of COVID-19, a disease caused by the SARS-CoV-2 virus, has created a public health crisis around the world. Early COVID-19 detection and isolation are key for controlling disease transmission and protecting vulnerable populations....

at 08:47
The Joint Corp. , the nation's largest provider of chiropractic care through The Joint Chiropractic® network, and Atlanta United recently signed an agreement naming The Joint as the Official Chiropractic Partner of Atlanta United. This is The Joint...

at 08:46
Businesses around the world were rocked with COVID-19, however, great innovation in both physical and digital storefronts came along. MobiDev experts defined the most important healthcare technology trends that can impact the retail industry in 2022....

at 08:45
The "Global AI in Healthcare Market (2021-2027) by Sections, Diagnosis, End user and Geography. IGR Competitive Analysis, Impact of Covid-19, Ansoff Analysis" report has been added to ResearchAndMarkets.com's offering. The Global AI in Healthcare...

at 08:45
The "Cognitive Assessment & Training in Healthcare Market Research Report by Assessment Type, by Component, by Application, by Region - Global Forecast to 2027 - Cumulative Impact of COVID-19" report has been added to ResearchAndMarkets.com's...

at 08:45
PFAS Exposuretm, the first at-home test to determine levels of PFAS in a person's blood and measure 47 of these PFAS "forever chemical" compounds, is now available from empowerDX, a leading online health and wellness resource for a wide variety of...



News published on 7 october 2021 at 14:36 and distributed by: